Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

21:05 EDT 29th May 2016 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

Reminder letter encourages more people to take bowel scope screening test

Jogging the memory with a reminder letter to those who don’t respond to their bowel scope screening invitation could mean more people would take the test, according to a Cancer Research UK-funded st...

GSK receives FDA Complete Response letter for Avodart for prostate cancer risk reduction supplemental indication

GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avo...

NEJM letter calls prostate cancer screening guidelines into question

Evidence now favors that prostate specific antigen (PSA) testing can help reduce the number of fatal cases of prostate cancer, contrary to earlier recommendations based on a landmark national study. R...

Research Breakthrough Could Lead to Better Prostate Cancer Treatment

Research breakthrough could lead to better prostate cancer treatment Cancer researchers from the University of Glasgow and Royal Philips Cancer researchers have identified a gene which could help doct...

Nanoparticles hitchhike on whiteblood cells to kill tumour cells in bloodstream.

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.  Most often, prostate cancer spreads to the bones and also to the liver or lungs. It’s rar...

Prostate Cancer: Year in Review

In 2015, the increased use of Oncotype DX prostate cancer test promoted changes in treatment received, resulting in greater recommendations and adoption of active surveillance. Also noteworthy is the ...

Reminder letters for bowel screening tests improve uptake

Only four in 10 people aged 55 currently accept the offer of a one-off flexible sigmoidoscopy screening test under NHS England’s bowel scope screening programme, but a reminder letter can boost... ...

Bone protein inhibits prostate cancer invasion, scientists find

A secreted protein predominantly expressed in bone inhibits prostate cancer metastasis to bone, new research shows. Prostate cancer is the most frequently diagnosed cancer and the second leading cause...

Matching PubMed Articles

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.

Compelling and long-standing data suggest that androgens play an important role in the development of both normal prostate epithelium and prostate cancer. Although testosterone administration can indu...

MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.

It is known that microRNAs (miRNAs) are a class of small, non-coding RNAs that act as key regulators in various physiological and pathological processes. However, the regulatory mechanisms involving m...

Immune Checkpoint Therapies in Prostate Cancer.

Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a ...

Vitamin D, PTH, and calcium in relation to survival following prostate cancer.

Epidemiological studies suggest that low levels of vitamin D constitute a risk factor for prostate cancer. However, the results are conflicting, perhaps because prostate cancer is a very heterogeneous...

Significance of p53 and ki-67 expression in prostate cancer.

Prostate cancer is a major health problem throughout the developed world. Tumor grade is one of the most important prognostic factors of prostate cancer. At present, adequate prognostic markers for pr...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement